You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -1,820.8% | -12.8% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -15.5 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 259.1 | 14.6 |
| Price / Book value | -679.8 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 197.7% | -5.7% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | -184.7% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2016-05-31 | 0.43 | -9.01 | -12.97p | -10.1 | 0.0 | n/a | n/a | 0.0% |
| 2017-05-31 | 0.21 | -5.32 | -9.84p | -14.3 | 0.0 | n/a | n/a | 0.0% |
| 2018-05-31 | 0.24 | -6.34 | -11.41p | -11.1 | 0.0 | n/a | n/a | 0.0% |
| 2019-05-31 | 0.17 | -8.55 | -12.97p | -7.1 | 0.0 | n/a | n/a | 0.0% |
| 2020-05-31 | 0.51 | -9.78 | -13.36p | -8.3 | 0.0 | n/a | n/a | 0.0% |
| Oncimmune signs two NHS contracts, has NICE guidance published Sharecast News | 14 Dec |
|---|---|
| Oncimmune enters deal with Augmenta to profile plasma samples Sharecast News | 11 Nov |
| Oncimmune granted funding for Covid-19 research collaboration Sharecast News | 06 Oct |
| Total Voting Rights | 01-Mar-21 07:01 |
|---|---|
| Interim Results | 15-Feb-21 07:00 |
| Notice of Half Year Results | 25-Jan-21 07:00 |
| Directorate Change | 19-Jan-21 16:19 |
| Holding(s) in Company | 18-Jan-21 11:38 |